RecruitingNCT05245903
Passive sensor monitoring and brain-energy markers in memory impairment
About this title
Read the official source — NCT05245903Observational studyAges 18–89United StatesMental health
Understand this study
Who could participate?
Listed age limits: 18 years to 89 years.
- Listed locations
- BelmontSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 31, 2022
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 40
- Sponsor
- Mclean Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Observational
- Intervention type
- Device
- Locations
- United States
- Age range
- From 18 Years to 89 Years
- Official registry ID
- NCT05245903
- Official title
Show the full official title
Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside on Bioenergetic Metabolism, Oxidative Stress, and Cognition in Mild Cognitive Impairment and Mild Alzheimer's Dementia
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Belmont
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Mclean Hospital, a hospital or academic medical center.
Who can participate?
Listed age limits: 18 years to 89 years.
Is this study still recruiting?
The registry lists this study as recruiting.
